Good morning Will I get Yselty medicine in Poland for the treatment / reduction of uterine fibroids? In June 2022 - the manufacturer applied for permission to sell this drug throughout the European Union. For several months I have been looking for this drug in pharmacies and I can not find anywhere. Thank you in advance for your reply.
* required field
* required field
Suggested Products
Space for your product
Angelika Talar-Śpionek Pharmacist, Editor
8 months ago
We have information from the manufacturer that the drug is already available in the country and should appear in the first pharmacies next week.
It is a drug from the Rpz category.
A medicinal product falls into the availability category "prescription for restricted use – Rpz" if:
1) the medicinal product is used in the treatment of diseases or clinical conditions that must be diagnosed in a hospital setting or in centres with appropriate diagnostic facilities, although administration and further care may be carried out elsewhere, or 2) the medicinal product is intended for outpatients but its use may cause a serious adverse reaction, and in the case of vaccines, a serious adverse reaction, and require special supervision during the treatment of the medicinal product and special medical supervision throughout the treatment period.
For medicines in this availability category, no specific prescription template is required.
You can track availability here:
https://www.gdziepolek.pl/produkty/129849/yselty-tabletki-powlekane/apteki
Hello, from what I found out today at the doctor's office, Yselty is now available in Poland. Is this true?
Angelika Talar-Śpionek Pharmacist, Editor
1 year ago
To @Kate: Yes, Ryego reduces the volume of the uterus and uterine fibroids. There are no studies comparing the two drugs, so we are not able to determine whether it will be similar. However, Ryego is indicated for the treatment of moderate to severe symptoms of uterine fibroids in adult women of childbearing potential.
Thank you for your reply. Does Ryeqo, like Yselty, cause a clear and constant reduction in the volume of the uterus and uterine fibroids? Because from what is on the leaflet Ryeqo is an indication for heavy menstruation.
Aleksandra Żywiec-Pelczar Pharmacist
1 year ago
In June 2022, the European Commission, as part of the central procedure, issued a decision on the marketing authorisation of Yselty in all European Union countries and EFTA countries – Iceland, Norway and Liechtenstein. Obtaining a marketing authorisation decision does not mean that the manufacturer will automatically market the drug to markets throughout Europe. That medicinal product is currently not distributed on Polish market. In 2021, a medicinal product with indications analogous to Yselta appeared on the Polish market - Ryeqo medicinal product indicated for use in the treatment of moderate to severe symptoms of uterine fibroids in adult women of childbearing age. The product can only be obtained with a prescription. Below is a link to track availability and on-line booking with pickup at the selected pharmacy: https://www.gdziepolek.pl/produkty/113699/ryeqo-tabletki-powlekane/apteki